References
- Daniels TE, Fox PC. Salivary and oral components of Sjogren's syndrome. Rheum Dis Clin North Am 1992;18:571-589.
- Ramos-Casals M, Tzioufas AG, Font J. Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis 2005;64:347-354.
- Liebow A, Carrington C. Lymphocytic interstitial pneumonia. Am J Pathol 1966;48:36a.
- Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest 2002;122:2150-2164. https://doi.org/10.1378/chest.122.6.2150
- Alkhayer M, McCann BG, Harrison BD. Lymphocytic interstitial pneumonitis in association with Sjogren's syndrome. Br J Dis Chest 1988;82:305-309. https://doi.org/10.1016/0007-0971(88)90074-5
- Dalvi V, Gonzalez EB, Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjogren's syndrome: a case report and a review of the literature. Clin Rheumatol 2007;26:1339-1343. https://doi.org/10.1007/s10067-006-0351-x
- Yum HK, Kim ES, Ok KS, Lee HK, Choi SJ. Lymphocytic interstitial pneumonitis associated with Epstein-Barr virus in systemic lupus erythematosus and Sjögren's syndrome. Complete remission with corticosteriod and cyclophosphamide. Korean J Intern Med 2002;17:198-203. https://doi.org/10.3904/kjim.2002.17.3.198
- Fishback N, Koss M. Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med 1996;2:429-433.
- Strimlan CV, Rosenow EC 3rd, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis: review of 13 cases. Ann Intern Med 1978;88:616-621. https://doi.org/10.7326/0003-4819-88-5-616
- Vitali C, Tavoni A, Viegi G, Begliomini E, Agnesi A, Bombardieri S. Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome. Ann Rheum Dis 1985;44:455-461. https://doi.org/10.1136/ard.44.7.455
- Constantopoulos SH, Papadimitriou CS, Moutsopoulos HM. Respiratory manifestations in primary Sjogren's syndrome: a clinical, functional, and histologic study. Chest 1985;88:226-229. https://doi.org/10.1378/chest.88.2.226
- Parambil JG, Myers JL, Lindell RM, Matteson EL, Ryu JH. Interstitial lung disease in primary Sjogren syndrome. Chest 2006;130:1489-1495. https://doi.org/10.1378/chest.130.5.1489
- Seror R, Sordet C, Guillevin L, et al. Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome. Ann Rheum Dis 2007;66:351-357. https://doi.org/10.1136/ard.2006.057919
- Devauchelle-Pensec V, Pennec Y, Morvan J, et al. Improvement of Sjogren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum 2007;57:310-317. https://doi.org/10.1002/art.22536
Cited by
- Rare case of idiopathic lymphocytic interstitial pneumonia exhibits good response to Mycophenolate Mofetil vol.9, pp.None, 2011, https://doi.org/10.1016/j.rmcr.2013.04.004
- Translation and Validation of a Korean Version of the Xerostomia Inventory in Patients with Primary Sjögren’s Syndrome vol.31, pp.5, 2011, https://doi.org/10.3346/jkms.2016.31.5.724
- Lymphocytic interstitial pneumonia in a patient with Sjögren's syndrome vol.33, pp.2, 2011, https://doi.org/10.12701/yujm.2016.33.2.112
- Lymphocytic interstitial pneumonia in a patient with mixed connective tissue disease – A case report vol.25, pp.None, 2011, https://doi.org/10.1016/j.rmcr.2018.06.003
- Cyanogenic glycoside amygdalin influences functions of human osteoblasts in vitro vol.56, pp.2, 2021, https://doi.org/10.1080/03601234.2020.1852054